Concepedia

Fotis Drakopanagiotakis

FD

Statistics

Publications

3

Citations

559

H-Index

3

Active since

2012

Affiliations

Sismanoglio General Hospital(Current)

Fotis Drakopanagiotakis is an author at Sismanoglio General Hospital specializing in medicine, hypoxia-inducible factor regulation, and immunopathology.

Publications per year

2012–2021

3

Publications

3

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial

Jürgen Behr, Antje Prasse, Michael Kreuter et al. · The Lancet Respiratory Medicine · 2021 · 516 citations · Full text

, , +9

Expression of Hypoxia-Inducible Factor (HIF)-1a-Vascular Endothelial Growth Factor (VEGF)-Inhibitory Growth Factor (ING)-4- axis in sarcoidosis patients

Αrgyris Τzouvelekis, Paschalis Ntolios, Andreas Karameris et al. · BMC Research Notes · 2012 · 29 citations · Full text

, , +14

Pirfenidone inhibits motility of NSCLC cells by interfering with the urokinase system

M. D. Kramer, Philipp Markart, Fotis Drakopanagiotakis et al. · Cellular Signalling · 2019 · 14 citations

, , +6

1–3 of 3